Heart health in MPN patients
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at heart and blood vessel problems in people with certain blood cancers called MPNs (myeloproliferative neoplasms). It aims to understand how these conditions affect the heart so doctors can better care for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Essential Thrombocythemia, Polycythemia Vera, or Primary Myelofibrosis.
- You are 18 years or older.
- You did not have a heart attack, stroke, heart failure, or high blood pressure before your MPN diagnosis.
- You do not have severe kidney or liver disease, or another active cancer besides MPN.
- You are not pregnant or breastfeeding.
- You agree to take part in the study at Assiut University Hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a regular exercise program can improve health and well-being for people with myeloproliferative neoplasms (a group of blood cancers). It is designed to help you feel stronger and manage your condition better.
This trial checks how common high blood pressure in the lungs is in people with blood cancers like polycythemia vera, essential thrombocythemia, chronic myeloid leukemia, and primary myelofibrosis. Researchers want to learn who is more at risk to help with early detection and treatment.
This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
This is a research registry for people who have certain blood cancers called myeloproliferative neoplasms (MPNs). It helps researchers learn about the disease over time and may help future studies find and compare patients.
This research study looks for specific immune system clues in patients with myeloproliferative neoplasms—rare blood disorders where your bone marrow produces too many blood cells. By identifying these markers, researchers hope to better understand and eventually treat these conditions.
Hear when a new Philadelphia Negative Myeloproliferative Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.